Finally, a full model was developed adjustment for risk factors with p < 0.05 in models 1–3 and all the variables significantly correlated with serum FGF21, to adequately investigate whether serum FGF21 was the independent risk factor for CAS and/or HP in patients with T2DM. Here, FGF21 is linked to type 2 diabetes mellitus.